DARPA invest in biotechnology
DARPA awarded CombiMatrix a contract to conduct basic research into their core technologies. See a press release here. The contract is worth up to $250 K. CombiMatrix works with molecules to develop detection systems for things like bio and chemical weapons. The technology also has commercial applications. DoD has put a lot of funding into a variety of technology to detect chemical and biological weapons beyond the current systems of swipe tests and sampling. This contract is just one small part of this effort and also illustrates how diverse the DoD Science and Technology (S&T) investment is.
DoD invests in automated medical diagnostic equipment
Filed under: CombiMatrix, Contract Awards, Department of Defense, IT, development program, logistics, medicine
CombiMatrix received a contract from DoD to continue development of hand-held diagnostic equipment for use in the field. See the press release here. The contract is worth over $900 K. DoD as well as other government agencies are evaluating products based on CombiMatrix’s systems to detect bacteriological and chemical systems. This contract builds upon those earlier efforts.





